L-Ornithine L-aspartate

CAS No. 3230-94-2

L-Ornithine L-aspartate ( Ornithine Aspartate )

Catalog No. M27087 CAS No. 3230-94-2

L-Ornithine L-aspartate lowers blood ammonia concentration and to eliminate symptoms of hepatic encephalopathy associated with liver cirrhosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 35 In Stock
500MG 65 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    L-Ornithine L-aspartate
  • Note
    Research use only, not for human use.
  • Brief Description
    L-Ornithine L-aspartate lowers blood ammonia concentration and to eliminate symptoms of hepatic encephalopathy associated with liver cirrhosis.
  • Description
    L-Ornithine L-aspartate lowers blood ammonia concentration and to eliminate symptoms of hepatic encephalopathy associated with liver cirrhosis.
  • Synonyms
    Ornithine Aspartate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    RIP3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3230-94-2
  • Formula Weight
    265.3
  • Molecular Formula
    C9H19N3O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N[C@@H](CC(O)=O)C(O)=O.N[C@@H](CCCN)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mandal P, et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell. 2014 Nov 20;56(4):481-95.
molnova catalog
related products
  • Hypromellose

    Hypromellose is a water-soluble hydrophilic, non-ionic cellulose ether.

  • ProTx III

    Potent Nav1.7 blocker (IC50 = 2.5 nM). Also inhibits Nav1.1, Nav1.2, Nav1.3 and Nav1.6 in the nanomolar range. Exhibits no effects on Cav channels or nAChR at 5 μM. Demonstrates analgesic activity in vivo; antagonizes effects of scorpion-venom toxin OD1 at Nav1.7.

  • LDN-212320

    LDN-212320 is a glutamate transporter EAAT2 activator. It also enhances EAAT2 levels by > 6 fold at concentrations < 5 μM after 24 h.